Miguel Melo

3.1k total citations
60 papers, 1.1k citations indexed

About

Miguel Melo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Miguel Melo has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 13 papers in Genetics. Recurrent topics in Miguel Melo's work include Thyroid Cancer Diagnosis and Treatment (24 papers), Diabetes Management and Research (7 papers) and Thyroid Disorders and Treatments (7 papers). Miguel Melo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (24 papers), Diabetes Management and Research (7 papers) and Thyroid Disorders and Treatments (7 papers). Miguel Melo collaborates with scholars based in Portugal, Spain and Brazil. Miguel Melo's co-authors include Francisco Carrilho, Paula Soares, Manuel Sobrinho‐Simões, Mara Ventura, Valdemar Máximo, Catarina Tavares, José Cameselle-Teijeiro, Adriana Gaspar da Rocha, Rui Batısta and João Vinagre and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Miguel Melo

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Melo Portugal 16 622 275 178 140 136 60 1.1k
Simona Censi Italy 19 701 1.1× 269 1.0× 193 1.1× 210 1.5× 63 0.5× 61 1.1k
Davide Nacamulli Italy 22 944 1.5× 207 0.8× 218 1.2× 175 1.3× 143 1.1× 39 1.2k
Yuichi Takashi Japan 18 217 0.3× 313 1.1× 115 0.6× 154 1.1× 105 0.8× 51 890
George Christodoulakos Greece 21 384 0.6× 135 0.5× 90 0.5× 240 1.7× 41 0.3× 55 1.3k
Margaret Warren-Perry United Kingdom 15 221 0.4× 315 1.1× 210 1.2× 238 1.7× 140 1.0× 20 845
Jung Hye Kim South Korea 17 288 0.5× 459 1.7× 162 0.9× 58 0.4× 56 0.4× 37 1.3k
Gábor Firneisz Hungary 18 280 0.5× 238 0.9× 187 1.1× 99 0.7× 146 1.1× 46 977
Meryl M. Petersen United Kingdom 17 453 0.7× 206 0.7× 329 1.8× 150 1.1× 103 0.8× 27 1.4k
P Lohse Germany 27 295 0.5× 586 2.1× 450 2.5× 253 1.8× 55 0.4× 57 1.4k
Andrew Palladino United States 20 589 0.9× 426 1.5× 341 1.9× 281 2.0× 29 0.2× 43 1.2k

Countries citing papers authored by Miguel Melo

Since Specialization
Citations

This map shows the geographic impact of Miguel Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Melo more than expected).

Fields of papers citing papers by Miguel Melo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Melo. The network helps show where Miguel Melo may publish in the future.

Co-authorship network of co-authors of Miguel Melo

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Melo. A scholar is included among the top collaborators of Miguel Melo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Melo. Miguel Melo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carvalho, Tânia, et al.. (2024). Medullary thyroid carcinoma - a 22-year case series from a tertiary hospital center. Endocrine Abstracts.
2.
Carreira, Ana, et al.. (2023). From Bariatric Surgery to Conception: The Ideal Timing to Optimize Fetal Weight. Obesity Surgery. 33(9). 2859–2865. 1 indexed citations
3.
Máximo, Valdemar, Miguel Melo, Yingjie Zhu, et al.. (2023). Genomic profiling of primary and metastatic thyroid cancers. Endocrine Related Cancer. 31(2). 5 indexed citations
4.
Carreira, Ana, et al.. (2023). Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 diabetes. Acta Diabetologica. 60(9). 1179–1185. 5 indexed citations
5.
Melo, Miguel, Roberto Attanasio, Laszlo Hegedüs, et al.. (2022). Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A THESIS Questionnaire Survey of Portuguese Endocrinologists. University of Southern Denmark Research Portal (University of Southern Denmark). 2 indexed citations
6.
Barros, Luísa, et al.. (2022). Hypoglycemia unawareness in type 1 diabetes patients using intermittent continuous glucose monitoring: Identification of risk factors and glycemic patterns. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 16(6). 102525–102525. 7 indexed citations
7.
Melo, Miguel, et al.. (2021). Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?. Diabetology & Metabolic Syndrome. 13(1). 81–81. 9 indexed citations
8.
Consoli, Agostino, Leszek Czupryniak, György Jermendy, et al.. (2020). Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel. Diabetes Obesity and Metabolism. 22(10). 1705–1713. 20 indexed citations
9.
Ventura, Mara, Miguel Melo, & Francisco Carrilho. (2019). Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1. Archives of Endocrinology and Metabolism. 63(5). 516–523. 10 indexed citations
10.
Caramelo, Francisco, et al.. (2019). Impacto do Uso Prolongado da Terapêutica Subcutânea Contínua com Insulina no Controlo da Diabetes Mellitus Tipo 1. Acta Médica Portuguesa. 32(1). 17–24. 3 indexed citations
11.
Santos, Liliana, Marcelo Correia, Paula Soares, et al.. (2018). Dynamin-Related Protein 1 at the Crossroads of Cancer. Genes. 9(2). 115–115. 69 indexed citations
12.
Cameselle‐Teijeiro, José, Ihab Abdulkader, Catarina Eloy, et al.. (2018). Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway. Modern Pathology. 31(8). 1168–1179. 51 indexed citations
13.
Melo, Miguel, Adriana Gaspar da Rocha, Rui Batısta, et al.. (2017). TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease. The Journal of Clinical Endocrinology & Metabolism. 102(6). 1898–1907. 109 indexed citations
14.
Tavares, Catarina, Maria João Coelho, Miguel Melo, et al.. (2016). pmTOR is a marker of aggressiveness in papillary thyroid carcinomas. Surgery. 160(6). 1582–1590. 7 indexed citations
15.
Durães, Cecília, Adélia Mendes, Liliana R. Santos, et al.. (2014). Polymorphisms in the TNFA and IL6 Genes Represent Risk Factors for Autoimmune Thyroid Disease. PLoS ONE. 9(8). e105492–e105492. 29 indexed citations
16.
Vinagre, João, Vasco Pinto, Ricardo Celestino, et al.. (2014). Telomerase promoter mutations in cancer: an emerging molecular biomarker?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(2). 119–133. 91 indexed citations
17.
Cameselle‐Teijeiro, José, Miguel Melo, Ihab Abdulkader, et al.. (2011). Estrogen receptors and progesterone receptor expression and their relationship to types of thyroid cancer. 26. 1 indexed citations
18.
Guimarães, Joana, Margarida Bastos, Miguel Melo, & Manuela Carvalheiro. (2007). Nefropatia diabética: taxa de filtração glomerular calculada e estimada.. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Melo, Miguel, et al.. (2003). Screening for cancer of the colon and rectum. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Rodrigues, Fernando, et al.. (1999). Thyroid Ultrasound Report: Consensus of the Thyroid Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism. Open Repository of the University of Porto (University of Porto). 0–0. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Censi Breakdown of academic impact, for papers by Davide Nacamulli Breakdown of academic impact, for papers by Yuichi Takashi Breakdown of academic impact, for papers by George Christodoulakos Breakdown of academic impact, for papers by Margaret Warren-Perry Breakdown of academic impact, for papers by Jung Hye Kim Breakdown of academic impact, for papers by Gábor Firneisz Breakdown of academic impact, for papers by Meryl M. Petersen Breakdown of academic impact, for papers by P Lohse Breakdown of academic impact, for papers by Andrew Palladino
Rankless by CCL
2026